Microscopic Diseases Remain in Initial Disseminated Sites After Neoadjuvant Chemotherapy for Stage III/IV Ovarian, Tubal, and Primary Peritoneal Cancer

Journal of Gynecologic Oncology - South Korea
doi 10.3802/jgo.2020.31.e34
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy (KAMJE)

Related search

Neoadjuvant Chemotherapy or Primary Surgery for Stage III/IV Ovarian Cancer: Contribution of Diagnostic Laparoscopy

BMC Cancer
Cancer ResearchOncologyGenetics
2009English

Primary Debulking Surgery Versus Primary Neoadjuvant Chemotherapy for High Grade Advanced Stage Ovarian Cancer: Comparison of Survivals

Radiology and Oncology
Nuclear MedicineRadiologyImagingOncology
2018English

Peritoneal Carcinomatosis Index as a Predictor of Diaphragmatic Involvement in Stage III and IV Ovarian Cancer

OncoTargets and Therapy
OncologyPharmacology
2018English

Ki67 Measured After Neoadjuvant Chemotherapy for Primary Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2013English

A Meta-Analysis: Neoadjuvant Chemotherapy Versus Primary Surgery in Ovarian Carcinoma FIGO stageIII and IV

World Journal of Surgical Oncology
SurgeryOncology
2013English

Intraperitoneal Chemotherapy for the Initial Management of Primary Epithelial Ovarian Cancer

Cochrane Database of Systematic Reviews
2016English

Intraperitoneal Chemotherapy for the Initial Management of Primary Epithelial Ovarian Cancer

2005English

Diaphragmatic Surgery and Related Complications in Primary Cytoreduction for Advanced Ovarian, Tubal, and Peritoneal Carcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2017English

Incorporating Robotic Surgery Into the Management of Ovarian Cancer After Neoadjuvant Chemotherapy

International Journal of Gynecological Cancer
GynecologyOncologyObstetrics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy